Table 4.
Surgical procedures and clinical complications
| Patients without in-hospital mortality (n=89) | Patients with in-hospital mortality (n=18) | P-value | |
|---|---|---|---|
| Surgical indication, n (%) | |||
| Congestive heart failure | 37 (41.6) | 10 (55.6) | |
| Uncontrolled infection | 24 (27.0) | 5 (27.8) | 0.406 |
| Embolism | 28 (31.5) | 3 (16.7) | |
| Surgery time (days) | 4±2 | 3±1 | 0.030 |
| Aortic valve surgery, n (%) | |||
| Mechanic prosthesis | 38 (42.7) | 6 (33.3) | |
| Bioprosthesis | 2 (2.2) | 6 (33.3)a | <0.001 |
| Annuloplasty | 2 (2.2) | 0 (0) | |
| Mitral valve surgery, n (%) | |||
| Mechanic prosthesis | 56 (62.9) | 8 (44.4) | |
| Bioprosthesis | 4 (4.5) | 5 (27.8)a | 0.008 |
| Annuloplasty | 6 (6.7) | 0 (0) | |
| Tricuspid valve surgery, n (%) | |||
| Prosthesis | 3 (3.4) | 1 (5.6) | 0.762 |
| Annuloplasty | 15 (16.9) | 4 (22.2) | |
| Coronary artery bypass grafting surgery, n (%) | 5 (5.6) | 2 (11.1) | 0.335 |
| Bentall operation, n (%) | 3 (3.4) | 1 (5.6) | 0.527 |
| Lead change, n (%) | 4 (4.5) | 1 (5.6) | 0.610 |
| Clinical complication, n (%) | |||
| Heart failure | 3 (3.4) | 3 (16.7) | 0.058 |
| Renal disease | 7 (7.9) | 4 (22.2) | 0.087 |
| Cerebrovascular accident | 2 (2.2) | 0 (0) | 0.691 |
| Intracerebral hemorrhage | 2 (2.2) | 0 (0) | 0.691 |
| Peripheral embolism | 3 (3.4) | 0 (0) | 0.572 |
| Rhythm disturbance | 9 (10.1) | 0 (0) | 0.177 |
| Septic shock | 1 (1.1) | 3 (16.7) | 0.015 |
| Pericarditis/myocarditis | 1 (1.1) | 0 (0) | 0.832 |
| Re-endocarditis | 3 (3.4) | 0 (0) | 0.572 |
a=higher than Group 1 with statistically significance.